Patent Number: 
Section: claims

1. A system for producing a radiopharmaceutical, said system comprising:a particle accelerator for generating a beam of charged particles having a maximum beam power of less than, or equal to, approximately 200 W, the beam consisting essentially of particles having a minimum energy greater than, or equal to, 5 MeV, and for directing the beam of charged particles along a path;a target positioned in the path of the beam of charged particles, said target serving to receive a target substance having a composition selected for producing a radioactive substance during interaction with the beam of charged particles; anda radiopharmaceutical micro-synthesis system having at least one microreactor and/or microfluidic chip, said radiopharmaceutical micro-synthesis system for receiving the radioactive substance, receiving at least one reagent, and synthesizing the radiopharmaceutical. 2. A biomarker generator for producing radiopharmaceuticals, said biomarker generator comprising:a target for holding a target substance that produces a selected radioisotope when bombarded by charged particles accelerated to energies greater than or equal to the nuclear binding energy of the target substance;a particle accelerator for generating a particle beam having a maximum beam power of 200 W, said particle beam comprising charged particles with an average energy at least equal to the nuclear binding energy of said target substance, said particle accelerator configured to bombard said target substance with said charged particles and produce said selected radioisotope; anda radiopharmaceutical micro-synthesis system comprising at least one microreactor or microfluidic chip, said radiopharmaceutical micro-synthesis system synthesizing a radiopharmaceutical from the selected radioisotope. 3. The biomarker generator of claim 2 wherein said average energy of said charged particles is within a range selected from the group consisting of 5 MeV to 18 MeV, 5 MeV to 10 MeV, 7 MeV to 10 MeV, 8 MeV to 10 MeV, and 7 MeV to 18 MeV. 4. The biomarker generator of claim 3 wherein said average energy of said charged particles is in the range of 5 MeV to 10 MeV. 5. The biomarker generator of claim 2 wherein said particle accelerator is a cyclotron and said charged particles are selected from the group consisting of protons and deuterons. 6. The biomarker generator of claim 5 wherein the target is located within a magnetic field generated by said cyclotron, said particle beam bombarding said target substance without exiting said magnetic field. 7. The biomarker generator of claim 2 wherein said charged particles are selected from the group consisting of protons and deuterons and wherein said average energy of said charged particles is in the range of 5 MeV to 10 MeV and said maximum beam power is 200 W. 8. The biomarker generator of claim 2 wherein said maximum beam power is selected from the group consisting of 50 W, 75 W, 100 W, 125 W, 150 W, and 175 W. 9. The biomarker generator of claim 8 wherein said maximum beam power is 50 W. 10. The biomarker generator of claim 2 producing said selected radioisotope per production run in a maximum quantity of approximately 2.59 GBq (70 mCi). 11. The biomarker generator of claim 2 wherein said selected radioisotope is 18F and said radiopharmaceutical is [18F]2-fluoro-2-deoxy-D-glucose, said particle accelerator producing a run of fluorine-18 with a maximum radioactivity selected from the group of approximately 0.666 GBq (18 mCi) and approximately 0.185 GBq (5 mCi). 12. A biomarker generator for producing on the order of one unit dose of a radiopharmaceutical, comprising:a target for holding a target substance that produces a selected radioisotope when bombarded by charged particles accelerated to energies greater than or equal to the nuclear binding energy of the target substance;a cyclotron for generating a particle beam having a maximum beam power in the range of 200 W, said particle beam comprising charged particles selected from the group consisting of protons and deuterons with an average energy in the range of 5 MeV to 10 MeV, said particle accelerator configured to bombard said target substance with said charged particles and produce said selected radioisotope; anda micro-reaction device for synthesizing a radiopharmaceutical from the selected radioisotope, said micro-reaction device comprising components selected from the group consisting of microfluidic reactors and microfluidic chips. 13. The biomarker generator of claim 12 wherein the target is located within a magnetic field generated by said cyclotron, said particle beam bombarding said target substance without exiting said magnetic field. 14. The biomarker generator of claim 12 producing said selected radioisotope per production run in a maximum quantity of approximately 2.59 GBq (70 mCi). 15. The biomarker generator of claim 12 wherein said selected radioisotope is 18F and said radiopharmaceutical is [18F]2-fluoro-2-deoxy-D-glucose, said particle accelerator producing a run of fluorine-18 with a maximum radioactivity selected from the group of approximately 0.666 GBq (18 mCi) and approximately 0.185 GBq (5 mCi). 16. The biomarker generator of claim 12 wherein said maximum beam power is selected from the group consisting of 50 W, 75 W, 100 W, 125 W, 150 W, and 175 W. 17. The biomarker generator of claim 16 wherein said maximum beam power is 50 W. 18. A method of producing on the order of one unit dose of a radiopharmaceutical, said method comprising the steps of:providing a target substance that produces a selected radioisotope when bombarded by charged particles accelerated to energies greater than or equal to the nuclear binding energy of the target substance;generating a particle beam of charged particles with a maximum beam power of 200 W, said charged particles selected from the group consisting of protons and deuterons, said charged particles accelerated to an average energy at least equal to the nuclear binding energy of said target substance;producing said radioisotope in a maximum quantity per production run on the order of one precursory unit dose from said target substance by bombarding said target substance with said charged particles;synthesizing said radioisotope into a maximum quantity of a radiopharmaceutical on the order of one unit dose using a micro-reaction device selected from the group consisting of microfluidic reactors and microfluidic chips. 19. The method of claim 18 wherein said step of generating a particle beam further comprising the step of providing a cyclotron to generate a particle beam, said method further comprising the steps of:locating the target substance in a magnetic field generated by said cyclotron; andbombarding said target substance with said particle beam without said particle beam exiting said magnetic field. 20. The method of claim 18 wherein said maximum quantity of said selected radioisotope produced per production run is approximately 2.59 GBq (70 mCi). 21. The method of claim 18 wherein said selected radioisotope is 18F and said radiopharmaceutical is [18F]2-fluoro-2-deoxy-D-glucose, said maximum quantity of said selected radiopharmaceutical produced per production run selected from the group of approximately 0.666 GBq (18 mCi) and approximately 0.185 GBq (5 mCi). 22. The method of claim 18 wherein said maximum beam power is selected from the group consisting of 50 W, 75 W, 100 W, 125 W, 150 W, and 175 W. 23. The method of claim 22 wherein said maximum beam power is 50 W. 24. The method of claim 18 wherein said average energy of said charged particles is within a range selected from the group consisting of 5 MeV to 18 MeV, 5 MeV to 10 MeV, 7 MeV to 10 MeV, 8 MeV to 10 MeV, and 7 MeV to 18 MeV. 25. The method of claim 24 wherein said average energy of said charged particles is in the range of 5 MeV to 10 MeV. 26. The method of claim 18 wherein said charged particles are selected from the group consisting of protons and deuterons and wherein said average energy of said charged particles is in the range of 5 MeV to 10 MeV and said maximum beam power is 200 W.